| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accessing health care autistically: a routine nasojejunal tube replacement
|
Larrington-Spencer, Harrie
|
|
|
|
9 |
p. 787-788
|
artikel
|
| 2 |
Access to hepatitis C care for people who inject drugs and people in prisons
|
Oru, Ena
|
|
2019
|
|
9 |
p. 662-663
|
artikel
|
| 3 |
Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis
|
Dajti, Elton
|
|
|
|
9 |
p. 816-828
|
artikel
|
| 4 |
Aggressive hydration and post-ERCP pancreatitis
|
Buxbaum, James
|
|
|
|
9 |
p. 686
|
artikel
|
| 5 |
Aggressive hydration and post-ERCP pancreatitis–Authors' reply
|
Weiland, Christina J Sperna
|
|
|
|
9 |
p. 686-687
|
artikel
|
| 6 |
Angioplasty with stenting for Budd-Chiari syndrome
|
Payancé, Audrey
|
|
2019
|
|
9 |
p. 657-659
|
artikel
|
| 7 |
Angioplasty with versus without routine stent placement for Budd-Chiari syndrome: a randomised controlled trial
|
Wang, Qiuhe
|
|
2019
|
|
9 |
p. 686-697
|
artikel
|
| 8 |
Bad blood
|
Burki, Talha Khan
|
|
2017
|
|
9 |
p. 634-
1 p.
|
artikel
|
| 9 |
Benralizumab for eosinophilic gastritis: a single-site, randomised, double-blind, placebo-controlled, phase 2 trial
|
Kliewer, Kara L
|
|
|
|
9 |
p. 803-815
|
artikel
|
| 10 |
Beyond disease activity to overall disease severity in inflammatory bowel disease
|
Koliani-Pace, Jenna L
|
|
2017
|
|
9 |
p. 624-626
3 p.
|
artikel
|
| 11 |
Boyce's sign in a large Zenker's diverticulum
|
Sharma, Suresh Chandra
|
|
2019
|
|
9 |
p. 742
|
artikel
|
| 12 |
Britta Siegmund: answering the big questions in IBD
|
Kirby, Tony
|
|
|
|
9 |
p. 786
|
artikel
|
| 13 |
BSG Annual Meeting 2017
|
Brierley, Rob
|
|
2017
|
|
9 |
p. 631-
1 p.
|
artikel
|
| 14 |
Can community pharmacists treat hepatitis C virus?
|
Wade, Amanda J
|
|
|
|
9 |
p. 790-791
|
artikel
|
| 15 |
Challenging stigma around alcohol misuse
|
Golshaie, Asal
|
|
|
|
9 |
p. 795
|
artikel
|
| 16 |
Clinical application of circulating tumour DNA in colorectal cancer
|
Loft, Matthew
|
|
|
|
9 |
p. 837-852
|
artikel
|
| 17 |
Clinical effectiveness of pharmacist-led versus conventionally delivered antiviral treatment for hepatitis C virus in patients receiving opioid substitution therapy: a pragmatic, cluster-randomised trial
|
Radley, Andrew
|
|
|
|
9 |
p. 809-818
|
artikel
|
| 18 |
Clinical trial designs for artificial intelligence in gastrointestinal endoscopy
|
Mori, Yuichi
|
|
|
|
9 |
p. 785-786
|
artikel
|
| 19 |
Coeliac disease: a protracted course to diagnosis
|
W, Natalie
|
|
2019
|
|
9 |
p. 673-674
|
artikel
|
| 20 |
Concomitant arterial and venous thromboembolism in ulcerative colitis
|
White, Lauren S
|
|
2017
|
|
9 |
p. 690-
1 p.
|
artikel
|
| 21 |
Controlling faecal incontinence in women by performing anal exercises with biofeedback or loperamide: a randomised clinical trial
|
Jelovsek, J Eric
|
|
2019
|
|
9 |
p. 698-710
|
artikel
|
| 22 |
Correction to Lancet Gastroenterol Hepatol 2017; 2: 565–75
|
|
|
2017
|
|
9 |
p. e6-
1 p.
|
artikel
|
| 23 |
Correction to Lancet Gastroenterol Hepatol 2018; 3: 603–13
|
|
|
2018
|
|
9 |
p. e4
|
artikel
|
| 24 |
Correction to Lancet Gastroenterol Hepatol 2023; published online July 4. https://doi.org/10.1016/S2468-1253(23)00157-7
|
|
|
|
|
9 |
p. e7
|
artikel
|
| 25 |
Cost of colorectal cancer care: sufficient to inform cancer policy?
|
IJzerman, Maarten J
|
|
|
|
9 |
p. 679-680
|
artikel
|
| 26 |
Derivation and validation of a novel risk score for safe discharge after acute lower gastrointestinal bleeding: a modelling study
|
Oakland, Kathryn
|
|
2017
|
|
9 |
p. 635-643
9 p.
|
artikel
|
| 27 |
Diagnostic yield of high-resolution manometry with a solid test meal for clinically relevant, symptomatic oesophageal motility disorders: serial diagnostic study
|
Ang, Daphne
|
|
2017
|
|
9 |
p. 654-661
8 p.
|
artikel
|
| 28 |
Differential diagnosis of inflammatory bowel disease: imitations and complications
|
Gecse, Krisztina B
|
|
2018
|
|
9 |
p. 644-653
|
artikel
|
| 29 |
Difficult-to-treat inflammatory bowel disease: results from an international consensus meeting
|
Parigi, Tommaso Lorenzo
|
|
|
|
9 |
p. 853-859
|
artikel
|
| 30 |
Double Duty
|
Goldberg, Ilana
|
|
|
|
9 |
p. 699
|
artikel
|
| 31 |
Drug-induced liver injury in older people
|
Lucena, M Isabel
|
|
|
|
9 |
p. 862-874
|
artikel
|
| 32 |
Early detection of gastric neoplasia: is artificial intelligence the solution?
|
Ahmad, Omer F
|
|
|
|
9 |
p. 678-679
|
artikel
|
| 33 |
Effect of a deep learning-based system on the miss rate of gastric neoplasms during upper gastrointestinal endoscopy: a single-centre, tandem, randomised controlled trial
|
Wu, Lianlian
|
|
|
|
9 |
p. 700-708
|
artikel
|
| 34 |
Efficacy and safety of the siRNA JNJ-73763989 and the capsid assembly modulator JNJ-56136379 (bersacapavir) with nucleos(t)ide analogues for the treatment of chronic hepatitis B virus infection (REEF-1): a multicentre, double-blind, active-controlled, randomised, phase 2b trial
|
Yuen, Man-Fung
|
|
|
|
9 |
p. 790-802
|
artikel
|
| 35 |
Eliminating viral hepatitis in the COVID-19 era: weighing challenge and opportunity
|
The Lancet Gastroenterology & Hepatology,
|
|
|
|
9 |
p. 789
|
artikel
|
| 36 |
Embracing early discharge in patients with lower gastrointestinal bleeding
|
Sengupta, Neil
|
|
2017
|
|
9 |
p. 620-621
2 p.
|
artikel
|
| 37 |
Endoscopic evaluation after surgery in inflammatory bowel disease
|
Syal, Gaurav
|
|
|
|
9 |
p. 690-691
|
artikel
|
| 38 |
Endoscopic evaluation after surgery in inflammatory bowel disease – Authors' reply
|
Shen, Bo
|
|
|
|
9 |
p. 691-692
|
artikel
|
| 39 |
Ensuring timely treatment of patients with primary biliary cholangitis
|
Marschall, Hanns-Ulrich
|
|
2018
|
|
9 |
p. 591-593
|
artikel
|
| 40 |
Enteropathogen detection in children with diarrhoea, or vomiting, or both, comparing rectal flocked swabs with stool specimens: an outpatient cohort study
|
Freedman, Stephen B
|
|
2017
|
|
9 |
p. 662-669
8 p.
|
artikel
|
| 41 |
Eosinophilic oesophagitis and type 2 inflammation multimorbidity: an opportunity for biologic treatment
|
Franceschini, Laura
|
|
|
|
9 |
p. 787-788
|
artikel
|
| 42 |
Examining Britain's “drink problem”
|
Burki, Talha Khan
|
|
2019
|
|
9 |
p. 672-673
|
artikel
|
| 43 |
Faecal microbiota transplantation for diarrhoea-predominant irritable bowel syndrome: a double-blind, randomised, placebo-controlled trial
|
Aroniadis, Olga C
|
|
2019
|
|
9 |
p. 675-685
|
artikel
|
| 44 |
Faecal microbiota transplantation for IBS: still a long way to go
|
Moayyedi, Paul
|
|
2019
|
|
9 |
p. 656-657
|
artikel
|
| 45 |
Fostering greener gastroenterology and hepatology practices
|
Burki, Talha
|
|
|
|
9 |
p. 794
|
artikel
|
| 46 |
Funding for gastrointestinal disease research in the European Union
|
Törnblom, Hans
|
|
2018
|
|
9 |
p. 593-595
|
artikel
|
| 47 |
Future directions in diagnostic gastrointestinal endoscopy
|
Rees, Colin J
|
|
2018
|
|
9 |
p. 595-597
|
artikel
|
| 48 |
Gastrointestinal and liver involvement in patients with COVID-19
|
Xu, Yongxing
|
|
|
|
9 |
p. 798-799
|
artikel
|
| 49 |
Gastrointestinal and liver involvement in patients with COVID-19
|
Barrera, Francisco J
|
|
|
|
9 |
p. 799
|
artikel
|
| 50 |
Gastrointestinal and liver involvement in patients with COVID-19 – Authors' reply
|
Qiu, Yun
|
|
|
|
9 |
p. 799-800
|
artikel
|
| 51 |
Gastrointestinal bleeding in patients with Helicobacter pylori and dual platelet inhibition after myocardial infarction
|
Hellström, Per M
|
|
|
|
9 |
p. 684-685
|
artikel
|
| 52 |
Gastrointestinal services in India during COVID-19: does governance matter?
|
Sarode, Gargi S
|
|
|
|
9 |
p. 692
|
artikel
|
| 53 |
Gastrointestinal services in India during COVID-19: does governance matter? – Authors' reply
|
Ramakrishnan, Arulraj
|
|
|
|
9 |
p. 692-693
|
artikel
|
| 54 |
Glecaprevir–pibrentasvir to treat chronic hepatitis C virus infection in Asia: two multicentre, phase 3 studies—a randomised, double-blind study (VOYAGE-1) and an open-label, single-arm study (VOYAGE-2)
|
Wei, Lai
|
|
|
|
9 |
p. 839-849
|
artikel
|
| 55 |
Global prevalence of hepatitis B virus infection and prevention of mother-to-child transmission
|
Xu, Chenyu
|
|
2018
|
|
9 |
p. 598-599
|
artikel
|
| 56 |
Global prevalence of hepatitis B virus infection and prevention of mother-to-child transmission
|
Zhou, Yi-Hua
|
|
2018
|
|
9 |
p. 598
|
artikel
|
| 57 |
Global prevalence of hepatitis B virus infection and prevention of mother-to-child transmission – Authors' reply
|
Razavi-Shearer, Devin
|
|
2018
|
|
9 |
p. 599
|
artikel
|
| 58 |
Global, regional, and national burden of hepatitis B, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019
|
|
|
|
|
9 |
p. 796-829
|
artikel
|
| 59 |
Gluten: dietary villain or innocent bystander?
|
Biesiekierski, Jessica R
|
|
|
|
9 |
p. 808
|
artikel
|
| 60 |
Health catastrophe: the toll of cholera in Yemen
|
The Lancet Gastroenterology & Hepatology,
|
|
2017
|
|
9 |
p. 619-
1 p.
|
artikel
|
| 61 |
Hepatitis C virus in sub-Saharan Africa: a long road to elimination
|
Shah, Rajiv
|
|
|
|
9 |
p. 693-694
|
artikel
|
| 62 |
Human liver flukes
|
Harrington, David
|
|
2017
|
|
9 |
p. 680-689
10 p.
|
artikel
|
| 63 |
Immune therapies in ulcerative colitis: are we beyond anti-TNF yet?
|
Raine, Tim
|
|
|
|
9 |
p. 794-796
|
artikel
|
| 64 |
Implementation of radiation segmentectomy for early-stage hepatocellular carcinoma
|
Lewandowski, Robert J
|
|
|
|
9 |
p. 783-784
|
artikel
|
| 65 |
Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases
|
Eslam, Mohammed
|
|
|
|
9 |
p. 743-753
|
artikel
|
| 66 |
Increasing access to colorectal cancer screening in the USA
|
The Lancet Gastroenterology & Hepatology,
|
|
|
|
9 |
p. 781
|
artikel
|
| 67 |
Inflammatory leg nodules following acute pancreatitis
|
Lehericey, Margot
|
|
|
|
9 |
p. 894
|
artikel
|
| 68 |
Inhibiting glucose absorption to treat constipation
|
Spiller, Robin
|
|
2018
|
|
9 |
p. 588-589
|
artikel
|
| 69 |
Is it time for a paradigm shift in treatment guidelines for chronic hepatitis B?
|
Johannessen, Asgeir
|
|
|
|
9 |
p. 784
|
artikel
|
| 70 |
Is there any alternative to science? Complementary and alternative therapies for inflammatory bowel diseases
|
Gomollón, Fernando
|
|
2019
|
|
9 |
p. 664-666
|
artikel
|
| 71 |
Laparoscopic versus open pancreatoduodenectomy for pancreatic or peri-ampullary tumours
|
van Hilst, Jony
|
|
|
|
9 |
p. 688-689
|
artikel
|
| 72 |
Laparoscopic versus open pancreatoduodenectomy for pancreatic or peri-ampullary tumours – Authors' reply
|
Wang, Min
|
|
|
|
9 |
p. 689-690
|
artikel
|
| 73 |
Management of metabolic syndrome and cardiovascular risk after liver transplantation
|
Fatourou, Evangelia M
|
|
2019
|
|
9 |
p. 731-741
|
artikel
|
| 74 |
Management of patients with hepatocellular carcinoma and portal vein tumour thrombosis: comparing east and west
|
Lu, Jian
|
|
2019
|
|
9 |
p. 721-730
|
artikel
|
| 75 |
Management of pouch neoplasia: consensus guidelines from the International Ileal Pouch Consortium
|
Kiran, Ravi P
|
|
|
|
9 |
p. 871-893
|
artikel
|
| 76 |
Medicine is missing its bedside manner
|
McIntosh, Kate V
|
|
2018
|
|
9 |
p. 602
|
artikel
|
| 77 |
More is not always better for novel hepatitis B therapies
|
Lens, Sabela
|
|
|
|
9 |
p. 772-773
|
artikel
|
| 78 |
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series
|
Domingo, Enric
|
|
2018
|
|
9 |
p. 635-643
|
artikel
|
| 79 |
NAFLD and liver-related events: does type 2 diabetes have a key role?
|
Vilar-Gomez, Eduardo
|
|
|
|
9 |
p. 777-778
|
artikel
|
| 80 |
Non-invasive diagnosis of liver fibrosis in patients with alcohol-related liver disease by transient elastography: an individual patient data meta-analysis
|
Nguyen-Khac, Eric
|
|
2018
|
|
9 |
p. 614-625
|
artikel
|
| 81 |
Non-steroidal anti-inflammatory drugs, intravenous fluids, pancreatic stents, or their combinations for the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a systematic review and network meta-analysis
|
Akshintala, Venkata S
|
|
|
|
9 |
p. 733-742
|
artikel
|
| 82 |
Novel antisense inhibition of diacylglycerol O-acyltransferase 2 for treatment of non-alcoholic fatty liver disease: a multicentre, double-blind, randomised, placebo-controlled phase 2 trial
|
Loomba, Rohit
|
|
|
|
9 |
p. 829-838
|
artikel
|
| 83 |
Odevixibat treatment in progressive familial intrahepatic cholestasis: a randomised, placebo-controlled, phase 3 trial
|
Thompson, Richard J
|
|
|
|
9 |
p. 830-842
|
artikel
|
| 84 |
Oesophageal manometry with a solid test meal: ready for prime time?
|
Katz, Philip O
|
|
2017
|
|
9 |
p. 621-623
3 p.
|
artikel
|
| 85 |
Oesophageal perforation
|
Carrascosa, Miguel F
|
|
2018
|
|
9 |
p. 654
|
artikel
|
| 86 |
Ozanimod in Crohn's disease: a promising new player
|
Sleutjes, Jasmijn A M
|
|
|
|
9 |
p. 791-792
|
artikel
|
| 87 |
Ozanimod induction therapy for patients with moderate to severe Crohn's disease: a single-arm, phase 2, prospective observer-blinded endpoint study
|
Feagan, Brian G
|
|
|
|
9 |
p. 819-828
|
artikel
|
| 88 |
Paraprobiotics for irritable bowel syndrome: all that glitters is not gold
|
Enck, Paul
|
|
|
|
9 |
p. 797
|
artikel
|
| 89 |
Paraprobiotics for irritable bowel syndrome: all that glitters is not gold – Authors' reply
|
Andresen, Viola
|
|
|
|
9 |
p. 797-798
|
artikel
|
| 90 |
Peg-interferon plus nucleotide analogue in patients with chronic hepatitis B with low viral load
|
Jindal, Ankur
|
|
2017
|
|
9 |
p. 628-
1 p.
|
artikel
|
| 91 |
Peg-interferon plus nucleotide analogue in patients with chronic hepatitis B with low viral load – Authors' reply
|
Jansen, Louis
|
|
2017
|
|
9 |
p. 629-
1 p.
|
artikel
|
| 92 |
Pharyngeal swallowing and oesophageal motility during a solid meal test: a prospective study in healthy volunteers and patients with major motility disorders
|
Hollenstein, Michael
|
|
2017
|
|
9 |
p. 644-653
10 p.
|
artikel
|
| 93 |
Polypoid lesions in the stomach and the colon: Cronkhite-Canada syndrome
|
Kunishi, Yosuke
|
|
|
|
9 |
p. 770
|
artikel
|
| 94 |
Poor disease knowledge among people living with hepatitis B in The Gambia and Tanzania
|
Vo-Quang, Erwan
|
|
|
|
9 |
p. 783-784
|
artikel
|
| 95 |
Poor Little Sick Girls: A Love Letter to Unacceptable Women
|
Islam, Tanzina
|
|
|
|
9 |
p. 788-789
|
artikel
|
| 96 |
Practice patterns of diagnostic upper gastrointestinal endoscopy during the initial COVID-19 outbreak in England
|
Markar, Sheraz R
|
|
|
|
9 |
p. 804-805
|
artikel
|
| 97 |
Preoperative oral antibiotics in colon surgery
|
Meyer, Jeremy
|
|
|
|
9 |
p. 801
|
artikel
|
| 98 |
Preoperative oral antibiotics in colon surgery
|
Lambregts, Merel M C
|
|
|
|
9 |
p. 800-801
|
artikel
|
| 99 |
Preoperative oral antibiotics in colon surgery
|
Koskenvuo, Laura
|
|
|
|
9 |
p. 801-802
|
artikel
|
| 100 |
Preoperative oral antibiotics in colon surgery – Authors' reply
|
Basany, Eloy Espin
|
|
|
|
9 |
p. 802-803
|
artikel
|
| 101 |
Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score
|
Carbone, Marco
|
|
2018
|
|
9 |
p. 626-634
|
artikel
|
| 102 |
Progress towards elimination of viral hepatitis by 2030 in the WHO Eastern Mediterranean Region, 2019
|
Alaama, Ahmed Sabry
|
|
|
|
9 |
p. 862-870
|
artikel
|
| 103 |
Quality evidence on interventions for faecal incontinence
|
Knowles, Charles H
|
|
2019
|
|
9 |
p. 659-660
|
artikel
|
| 104 |
Radiation segmentectomy for curative intent of unresectable very early to early stage hepatocellular carcinoma (RASER): a single-centre, single-arm study
|
Kim, Edward
|
|
|
|
9 |
p. 843-850
|
artikel
|
| 105 |
Rare cause of dysphagia in a young woman
|
Alwali, Ahmed
|
|
|
|
9 |
p. 860
|
artikel
|
| 106 |
Rectal swabs: a diagnostic alternative in paediatric gastroenteritis?
|
Wine, Eytan
|
|
2017
|
|
9 |
p. 623-624
2 p.
|
artikel
|
| 107 |
Reduced rate of hospital admissions for liver-related morbidities during the initial COVID-19 outbreak
|
Eshraghian, Ahad
|
|
|
|
9 |
p. 803-804
|
artikel
|
| 108 |
Research in Brief
|
Baker, Holly
|
|
|
|
9 |
p. 793
|
artikel
|
| 109 |
Research in brief
|
Baker, Holly
|
|
2017
|
|
9 |
p. 632-
1 p.
|
artikel
|
| 110 |
Research in brief
|
Baker, Holly
|
|
2018
|
|
9 |
p. 600
|
artikel
|
| 111 |
Research in brief
|
Baker, Holly
|
|
2019
|
|
9 |
p. 669
|
artikel
|
| 112 |
Research in Brief
|
Baker, Holly
|
|
|
|
9 |
p. 698
|
artikel
|
| 113 |
Research in brief
|
Baker, Holly
|
|
|
|
9 |
p. 807
|
artikel
|
| 114 |
Research in Brief
|
Baker, Holly
|
|
|
|
9 |
p. 785
|
artikel
|
| 115 |
Safety and activity of ivosidenib in patients with IDH1-mutant advanced cholangiocarcinoma: a phase 1 study
|
Lowery, Maeve A
|
|
2019
|
|
9 |
p. 711-720
|
artikel
|
| 116 |
Safety and efficacy of the sodium-glucose cotransporter 1 inhibitor mizagliflozin for functional constipation: a randomised, placebo-controlled, double-blind phase 2 trial
|
Fukudo, Shin
|
|
2018
|
|
9 |
p. 603-613
|
artikel
|
| 117 |
Safety, pharmacokinetics, and antiviral activity of RO7049389, a core protein allosteric modulator, in patients with chronic hepatitis B virus infection: a multicentre, randomised, placebo-controlled, phase 1 trial
|
Yuen, Man-Fung
|
|
|
|
9 |
p. 723-732
|
artikel
|
| 118 |
Simplifying the path to elimination of hepatitis C
|
The Lancet Gastroenterology & Hepatology,
|
|
|
|
9 |
p. 781
|
artikel
|
| 119 |
Small molecule oral targeted therapies in ulcerative colitis
|
Shivaji, Uday N
|
|
|
|
9 |
p. 850-861
|
artikel
|
| 120 |
Spleen stiffness to identify clinically significant portal hypertension
|
Ripoll, Cristina
|
|
|
|
9 |
p. 775-776
|
artikel
|
| 121 |
Stringent criteria for withdrawal of biologics in ulcerative colitis
|
Tan, Malcolm
|
|
|
|
9 |
p. 687-688
|
artikel
|
| 122 |
Stringent criteria for withdrawal of biologics in ulcerative colitis – Authors' reply
|
Kobayashi, Taku
|
|
|
|
9 |
p. 688
|
artikel
|
| 123 |
Targeted therapy for cholangiocarcinoma
|
Valle, Juan W
|
|
2019
|
|
9 |
p. 661-662
|
artikel
|
| 124 |
Targeting type 2 immune responses to treat eosinophilic gastritis
|
Burns, Grace L
|
|
|
|
9 |
p. 773-775
|
artikel
|
| 125 |
16th Congress of the European Crohn's and Colitis Organisation
|
Brierley, Rob
|
|
|
|
9 |
p. 696-697
|
artikel
|
| 126 |
The Adventures of Captain Immunity
|
O'Connor, Aine
|
|
2017
|
|
9 |
p. 633-
1 p.
|
artikel
|
| 127 |
The challenge of inflammatory bowel disease in India
|
Furlow, Bryant
|
|
2019
|
|
9 |
p. 670-671
|
artikel
|
| 128 |
The Chills: The Triumph and Tragedy of Martin Phillipps
|
Higgs, Victoria
|
|
2019
|
|
9 |
p. 671-672
|
artikel
|
| 129 |
The economic burden of colorectal cancer across Europe: a population-based cost-of-illness study
|
Henderson, Raymond Hugo
|
|
|
|
9 |
p. 709-722
|
artikel
|
| 130 |
The first new drug for progressive familial intrahepatic cholestasis
|
Hsu, Shu-Hao
|
|
|
|
9 |
p. 782-783
|
artikel
|
| 131 |
The great obesity debate: divided we fall
|
The Lancet Gastroenterology & Hepatology,
|
|
2019
|
|
9 |
p. 655
|
artikel
|
| 132 |
The harms of early cessation of trials on systematic reviews
|
Fairfield, Cameron J
|
|
2019
|
|
9 |
p. 667
|
artikel
|
| 133 |
The harms of early cessation of trials on systematic reviews – Authors' reply
|
Dijkgraaf, Marcel G
|
|
2019
|
|
9 |
p. 667-668
|
artikel
|
| 134 |
The Hep B Calculator: an online tool for cost-effectiveness analyses of treatment
|
Toy, Mehlika
|
|
2019
|
|
9 |
p. 668
|
artikel
|
| 135 |
The impact of COVID-19 on hepatitis elimination
|
Wingrove, Chris
|
|
|
|
9 |
p. 792-794
|
artikel
|
| 136 |
The impact of COVID-19 on hepatitis services and civil society organisations
|
Wingrove, Chris
|
|
|
|
9 |
p. 682-684
|
artikel
|
| 137 |
The International Liver Congress 2022
|
Brierley, Rob
|
|
|
|
9 |
p. 792
|
artikel
|
| 138 |
The International Liver Congress 2021
|
Thomas, Hugh
|
|
|
|
9 |
p. 695
|
artikel
|
| 139 |
The Lancet Gastroenterology & Hepatology: 5 years on
|
The Lancet Gastroenterology & Hepatology,
|
|
|
|
9 |
p. 677
|
artikel
|
| 140 |
Theodor Billroth: ushering in the modern era
|
Burki, Talha Khan
|
|
2018
|
|
9 |
p. 601
|
artikel
|
| 141 |
The potential immune regulation benefit of CpAMs beyond HBV suppression
|
Wu, Di
|
|
|
|
9 |
p. 680-682
|
artikel
|
| 142 |
The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis
|
Riazi, Kiarash
|
|
|
|
9 |
p. 851-861
|
artikel
|
| 143 |
The role of precision nutrition in the modulation of microbial composition and function in people with inflammatory bowel disease
|
Sasson, Alexa N
|
|
|
|
9 |
p. 754-769
|
artikel
|
| 144 |
The top 10 research priorities for pancreatitis: findings from a James Lind Alliance priority setting partnership
|
Mitra, Vikramjit
|
|
|
|
9 |
p. 780-782
|
artikel
|
| 145 |
Transient elastography for alcoholic liver disease: a step forward
|
Pose, Elisa
|
|
2018
|
|
9 |
p. 589-591
|
artikel
|
| 146 |
Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis
|
Huang, Daniel Q
|
|
|
|
9 |
p. 829-836
|
artikel
|
| 147 |
UK Government announces contaminated blood inquiry
|
Kirby, Tony
|
|
2017
|
|
9 |
p. 630-
1 p.
|
artikel
|
| 148 |
Unmet needs of patients with irritable bowel syndrome
|
The Lancet Gastroenterology & Hepatology,
|
|
2018
|
|
9 |
p. 587
|
artikel
|
| 149 |
Unsilencing liver disease
|
The Lancet Gastroenterology & Hepatology,
|
|
|
|
9 |
p. 771
|
artikel
|
| 150 |
Use of Cytosponge as a triaging tool to upper gastrointestinal endoscopy during the COVID-19 pandemic
|
di Pietro, Massimiliano
|
|
|
|
9 |
p. 805-806
|
artikel
|
| 151 |
Variceal embolisation plus TIPS for variceal bleeding
|
Zhu, Yongjun
|
|
|
|
9 |
p. 789-790
|
artikel
|
| 152 |
Variceal embolisation plus TIPS for variceal bleeding
|
Luo, Xuefeng
|
|
|
|
9 |
p. 789
|
artikel
|
| 153 |
Variceal embolisation plus TIPS for variceal bleeding – Authors' reply
|
Lv, Yong
|
|
|
|
9 |
p. 790-791
|
artikel
|
| 154 |
Viral hepatitis in Asia-Pacific: a post-COVID-19 reset
|
Wallace, Jack
|
|
|
|
9 |
p. 778-780
|
artikel
|
| 155 |
Virtual ESMO World Congress on Gastrointestinal Cancer 2021
|
Pinion, Sheila
|
|
|
|
9 |
p. 696
|
artikel
|
| 156 |
Watch-and-wait approach for rectal cancer: concepts of a subject-specific method
|
Renehan, Andrew G
|
|
2017
|
|
9 |
p. 627-
1 p.
|
artikel
|
| 157 |
Watch-and-wait approach for rectal cancer: concepts of a subject-specific method – Authors' reply
|
Dossa, Fahima
|
|
2017
|
|
9 |
p. 627-628
2 p.
|
artikel
|
| 158 |
Wolman's disease and cholesteryl ester storage disorder: the phenotypic spectrum of lysosomal acid lipase deficiency
|
Pericleous, Marinos
|
|
2017
|
|
9 |
p. 670-679
10 p.
|
artikel
|
Tijdschrift beschrijving